MCCORMICK & CO INC·4

Feb 9, 3:41 PM ET

Tapiero Jacques 4

4 · MCCORMICK & CO INC · Filed Feb 9, 2026

Research Summary

AI-generated summary of this filing

Updated

McCormick (MKC) Director Jacques Tapiero Exercises Options, Sells Shares

What Happened

  • Director Jacques Tapiero exercised/converted derivatives to acquire 5,000 McCormick (MKC) shares on 2026-02-05 (recorded purchase value $249,800 at $49.96/share) and sold 5,000 shares the same day in an open-market sale for $67.09/share (proceeds $335,450). The filing also shows a derivative conversion/settlement line at $0 and a subsequent grant of 2,598 restricted stock units (RSUs) on 2026-02-06 (no cash paid). The same-day exercise and sale is effectively a cashless exercise followed by a sale (sale proceeds exceed the exercise cost).

Key Details

  • Transaction dates and prices:
    • 2026-02-05: Exercised/conversion (M) 5,000 shares @ $49.96 — cost $249,800 (Acquired).
    • 2026-02-05: Open-market sale (S) 5,000 shares @ $67.09 — proceeds $335,450 (Disposed).
    • 2026-02-05: Exercise/conversion (M) 5,000 shares @ $0.00 — listed as a derivative disposition (no cash value).
    • 2026-02-06: Grant/award (A) 2,598 RSUs @ $0.00 — reported as an acquisition of a contingent right.
  • Shares owned after transaction: Not specified in the information provided in this summary (see filing for total beneficial ownership).
  • Footnotes of note:
    • F1: Phantom stock = right to receive one voting share; payable in shares under the Non‑Qualified Retirement Savings Plan.
    • F2: Option exercised; no purchase price required for that entry (explains the $0.00 exercise line).
    • F3: Each RSU is a contingent right to one share.
    • F4: The RSUs vest in full on 2027-02-15 and will be settled in McCormick shares.
  • Filing timeliness: Transaction reported on Form 4 filed 2026-02-09 for transactions on 2026-02-05. That filing date appears timely (filed within the standard reporting window).

Context

  • This was an exercise/conversion of derivative awards followed by an immediate open‑market sale of the same number of shares — a common cashless-exercise pattern where options/derivatives are converted and shares are sold to cover costs or take gains. The RSU grant is a separate award that vests in Feb 2027 and will convert into shares at vesting; it does not represent an immediate purchase or sale. As always, filings state transactions but do not explain the insider’s motives.

Insider Transaction Report

Form 4
Period: 2026-02-05
Transactions
  • Exercise/Conversion

    Common Stock - Voting

    2026-02-05$49.96/sh+5,000$249,80036,596.054 total
  • Sale

    Common Stock - Voting

    2026-02-05$67.09/sh5,000$335,45031,596.054 total
  • Exercise/Conversion

    Options - Right to Buy

    [F2]
    2026-02-055,0000 total
    Exercise: $67.09From: 2017-03-30Exp: 2026-03-29Common Stock - Voting (5,000 underlying)
  • Award

    Restricted Stock Units

    [F3][F4]
    2026-02-06+2,5982,598 total
    Common Stock - Voting (2,598 underlying)
Holdings
  • Common Stock - Non Voting

    2,620
  • Phantom Stock

    [F1]
    (indirect: Non Qualified Retirement Savings Plan)
    Common Stock - Voting (0 underlying)
    2,206.082
Footnotes (4)
  • [F1]Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan.
  • [F2]Option exercised; no purchase price required.
  • [F3]The Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
  • [F4]The Restricted Stock Units vest in full on 2/15/2027 and are settled in an equal number of shares of McCormick stock.
Signature
Jason E. Wynn, Attorney-in-fact|2026-02-09

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES